Home > Financial Ratios > LAURUS LABS
COMMUNITY POLL
for LAURUS LABS
Please provide your vote to see the results

LAURUS LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 40.62-49.7011.16-8.68175.97

What is the latest Core EBITDA Growth ratio of LAURUS LABS ?

The latest Core EBITDA Growth ratio of LAURUS LABS is 40.62 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202540.62
Mar2024-49.70
Mar202311.16
Mar2022-8.68
Mar2021175.97

How is Core EBITDA Growth of LAURUS LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 40.62
Positive
Mar2024 -49.7
Negative
Mar2023 11.16
Positive
Mar2022 -8.68
Negative
Mar2021 175.97 -

Other Financial Ratios of LAURUS LABS


Compare Core EBITDA Growth ratio of peers of LAURUS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LAURUS LABS ₹73,512.8 Cr 1.4% 24.9% 132.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


LAURUS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LAURUS LABS

1.4%

24.9%

132.9%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses